Home  >  Products  >  CEACAM3 (carcinoembryonic antigen-related cell adhesion molecule 3) Blocking Peptide (the C terminal of CEACAM3)(100ug)
CEACAM3 (carcinoembryonic antigen-related cell adhesion molecule 3) Blocking Peptide (the C terminal of CEACAM3)(100ug)

CEACAM3 (carcinoembryonic antigen-related cell adhesion molecule 3) Blocking Peptide (the C terminal of CEACAM3)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-CEACAM3 Antibody (ARP60120_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP60120
Size: 100ug
Weight: 23kDa
Gene: 1084
Format: Lyophilized powder
Target: This gene encodes a member of the family of carcinoembryonic antigen-related cell adhesion molecules (CEACAMs), which are used by several bacterial pathogens to bind and invade host cells. The encoded transmembrane protein directs phagocytosis of several bacterial species that is dependent on the small GTPase Rac. It is thought to serve an important role in controlling human-specific pathogens by the innate immune system. Alternatively spliced transcript variants have been described, but their biological validity has not been determined.
Alternative names: CD66D; CEA; CGM1; MGC119875; W264; W282
See Full Product Listings >